Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Allakos Inc (NQ: ALLK )

81.67 -0.43 (-0.52%)
Streaming Delayed Price Updated: 2:46 PM EDT, Jul 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 86,445
Open 81.77
Bid (Size) 81.50 (1)
Ask (Size) 81.85 (1)
Prev. Close 82.10
Today's Range 80.89 - 82.78
52wk Range 73.75 - 157.98
Shares Outstanding 53,569,720
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Allakos Completes Patient Enrollment in Phase 3 Eosinophilic Gastritis and/or Eosinophilic Duodenitis and Phase 2/3 Eosinophilic Esophagitis Clinical Trials of Lirentelimab (AK002)
From GlobeNewswire News Releases
New Allakos Data Presented at DDW 2021 Suggest that Eosinophilic Gastritis and/or Eosinophilic Duodenitis (EG/EoD) is Highly Underdiagnosed and may be a Common Cause of Moderate-to-Severe Gastrointest
45% (181/405) of patients with chronic functional gastrointestinal symptoms who underwent upper endoscopy with biopsy met the diagnostic criteria for eosinophilic gastritis and/or eosinophilic... 
From GlobeNewswire News Releases

Performance

YTD
-38.95%
-38.95%
1 Month
-11.51%
-11.51%
3 Month
-25.68%
-25.68%
6 Month
-37.89%
-37.89%
1 Year
-3.37%
-3.37%

More News

Read More
Allakos Reports First Quarter 2021 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Allakos Appoints Baird Radford as Chief Financial Officer
From GlobeNewswire News Releases
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2021 DDW Annual Meeting
From GlobeNewswire News Releases
Allakos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Sum Up The Parts: ESGV Could Be Worth $86
Tags ETFs
From ETF Channel
RiverVest Venture Partners Closes $275 Million Life Sciences Fund
From Business Wire News Releases
How The Parts Add Up: ESML Targets $43
Tags ETFs
From ETF Channel
3 Biotech Stocks That Could Double Soon
Tags AFMD Market News ALLK
From Motley Fool
7 of the Best Pharma Stocks to Buy Now
Tags SWTX IBRX SAGE
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.